fever; tachycardia; This is a spontaneous report from a contactable nurse.  A female patient of an unspecified age (pregnancy status not reported) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, on 03Jan2021 as a single dose for COVID-19 immunization. Indication. Medical history and concomitant medications were not reported. I was not known if the patient received other vaccinations in last 4 weeks or if she took any medications in the past 2 weeks. It was not reported if the patient had been tested for COVID-19 prior to the vaccination.  The patient reported fever, tachycardia following administration of vaccine. She was scheduled to receive second dose 30Jan2021 and was questioning safety of second administration. The clinical outcome of the fever and tachycardia was not reported. It was unknown if the patient was tested for COVID-19 after the vaccination.  Information on the lot/batch number has been requested.